Objective: The purpose of this study was to explore the clinical features and risk factors of outcomes in pediatric posterior cranial fossa ependymoma. We aim to provide evidence-based recommendations for the improvement of prognoses. Patients and Methods: The clinical data, treatment modalities, approaches performed, recurrence rates and times, as well as the outcomes of 94 cases were analyzed retrospectively. The characters of neuroimaging were further studied. Results: In data from the most recent follow-up, 27 cases had tumor recurrence. The time for tumor recurrence was 13.7 ± 7.7 months. The estimated overall survival and progression-free survival, based on Kaplan-Meier analysis, was 42.2 ± 2.9 months and 38.7 ± 3.4 months, respectively. Univariate analysis showed that being free of recurrence is closely related to the high tumor sphericity (p = 0.018), homogeneity of tumor texture (p = 0.001), and gross total resection (GTR; p < 0.001). Mortality is linked to low sphericity (p = 0.017) and brain stem edema (p = 0.005). Cerebellar mutism is correlated with posterosuperior compression of the 4th ventricle roof by the tumor. The incidence rate of cerebellar ataxia, cerebellar mutism, and cerebellar dysarthria is related to the rostral extension of the tumor within the 4th ventricle. The recurrence rate is higher in subtotal resection (STR) than in GTR, and the difference is significant (p < 0.001). Although there is no significant difference between the recurrence rates in the three types, an earlier recurrence is prone with tumors located in the paramidline-lateral compared to the midline (p = 0.021) and paramidline-medial areas (p = 0.042). Conclusions: Based on our data, GTR is indicated as the most optimal choice. Recurrence is linked to lower tumor sphericity, inhomogeneous tumor texture, and STR/partial resection. Tumor located on the lateral side might be prone for an early recurrence.

1.
Gurney
JG
,
Severson
RK
,
Davis
S
,
Robison
LL
.
Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type
.
Cancer
.
1995
Apr
;
75
(
8
):
2186
95
.
[PubMed]
0008-543X
2.
Kuratsu
J
,
Ushio
Y
.
Epidemiological study of primary intracranial tumors: a regional survey in Kumamoto Prefecture in the southern part of Japan
.
J Neurosurg
.
1996
Jun
;
84
(
6
):
946
50
.
[PubMed]
0022-3085
3.
Mehrazin
M
,
Yavari
P
.
Morphological pattern and frequency of intracranial tumors in children
.
Childs Nerv Syst
.
2007
Feb
;
23
(
2
):
157
62
.
[PubMed]
0256-7040
4.
Miller
RW
,
Young
JL
 Jr
,
Novakovic
B
.
Childhood cancer
.
Cancer
.
1995
Jan
;
75
(
1
Suppl
):
395
405
.
[PubMed]
0008-543X
5.
Monteith
SJ
,
Heppner
PA
,
Woodfield
MJ
,
Law
AJ
.
Paediatric central nervous system tumours in a New Zealand population: a 10-year experience of epidemiology, management strategies and outcomes
.
J Clin Neurosci
.
2006
Aug
;
13
(
7
):
722
9
.
[PubMed]
0967-5868
6.
Wright
KD
,
Gajjar
A
.
Current treatment options for pediatric and adult patients with ependymoma
.
Curr Treat Options Oncol
.
2012
Dec
;
13
(
4
):
465
77
.
[PubMed]
1527-2729
7.
Taylor
MD
,
Poppleton
H
,
Fuller
C
,
Su
X
,
Liu
Y
,
Jensen
P
, et al.
Radial glia cells are candidate stem cells of ependymoma
.
Cancer Cell
.
2005
Oct
;
8
(
4
):
323
35
.
[PubMed]
1535-6108
8.
Taylor
RE
.
Review of radiotherapy dose and volume for intracranial ependymoma
.
Pediatr Blood Cancer
.
2004
May
;
42
(
5
):
457
60
.
[PubMed]
1545-5009
9.
Ramaswamy
V
,
Hielscher
T
,
Mack
SC
,
Lassaletta
A
,
Lin
T
,
Pajtler
KW
, et al.
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis
.
J Clin Oncol
.
2016
Jul
;
34
(
21
):
2468
77
.
[PubMed]
0732-183X
10.
Ailon
T
,
Dunham
C
,
Carret
AS
,
Tabori
U
,
Mcneely
PD
,
Zelcer
S
, et al.
The role of resection alone in select children with intracranial ependymoma: the Canadian Pediatric Brain Tumour Consortium experience
.
Childs Nerv Syst
.
2015
Jan
;
31
(
1
):
57
65
.
[PubMed]
0256-7040
11.
Smith
MA
,
Seibel
NL
,
Altekruse
SF
,
Ries
LA
,
Melbert
DL
,
O’Leary
M
, et al.
Outcomes for children and adolescents with cancer: challenges for the twenty-first century
.
J Clin Oncol
.
2010
May
;
28
(
15
):
2625
34
.
[PubMed]
0732-183X
12.
McGuire
CS
,
Sainani
KL
,
Fisher
PG
.
Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study
.
J Neurosurg
.
2009
Apr
;
110
(
4
):
725
9
.
[PubMed]
0022-3085
13.
Dohrmann
GJ
,
Farwell
JR
.
Ependymal neoplasms in children
.
Trans Am Neurol Assoc
.
1976
;
101
:
125
9
.
[PubMed]
0065-9479
14.
Vera-Bolanos
E
,
Aldape
K
,
Yuan
Y
,
Wu
J
,
Wani
K
,
Necesito-Reyes
MJ
, et al.;
CERN Foundation
.
Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients
.
Neuro-oncol
.
2015
Mar
;
17
(
3
):
440
7
.
[PubMed]
1522-8517
15.
Louis
DN
,
Ohgaki
H
,
Wiestler
OD
,
Cavenee
WK
,
Burger
PC
,
Jouvet
A
, et al.
The 2007 WHO classification of tumours of the central nervous system
.
Acta Neuropathol
.
2007
Aug
;
114
(
2
):
97
109
.
[PubMed]
0001-6322
16.
Amirian
ES
,
Armstrong
TS
,
Aldape
KD
,
Gilbert
MR
,
Scheurer
ME
.
Predictors of survival among pediatric and adult ependymoma cases: a study using Surveillance, Epidemiology, and End Results data from 1973 to 2007
.
Neuroepidemiology
.
2012
;
39
(
2
):
116
24
.
[PubMed]
0251-5350
17.
Araki
A
,
Chocholous
M
,
Gojo
J
,
Dorfer
C
,
Czech
T
,
Heinzl
H
, et al.
Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma
.
Acta Neuropathol Commun
.
2016
Aug
;
4
(
1
):
88
.
[PubMed]
2051-5960
18.
Tsangaris
GT
,
Papathanasiou
C
,
Adamopoulos
PG
,
Scorilas
A
,
Vorgias
CE
,
Prodromou
N
, et al.
Pediatric Ependymoma: A Proteomics Perspective
.
Cancer Genomics Proteomics
.
2017
Mar-Apr
;
14
(
2
):
127
36
.
[PubMed]
1109-6535
19.
Sergeant
A
,
Kameda-Smith
MM
,
Manoranjan
B
,
Karmur
B
,
Duckworth
J
,
Petrelli
T
, et al.
Analysis of surgical and MRI factors associated with cerebellar mutism
.
J Neurooncol
.
2017
Jul
;
133
(
3
):
539
52
.
[PubMed]
0167-594X
20.
Reed-Berendt
R
,
Phillips
B
,
Picton
S
,
Chumas
P
,
Warren
D
,
Livingston
JH
, et al.
Cause and outcome of cerebellar mutism: evidence from a systematic review
.
Childs Nerv Syst
.
2014
Mar
;
30
(
3
):
375
85
.
[PubMed]
0256-7040
21.
van Baarsen
KM
,
Grotenhuis
JA
.
The anatomical substrate of cerebellar mutism
.
Med Hypotheses
.
2014
Jun
;
82
(
6
):
774
80
.
[PubMed]
0306-9877
22.
Merchant
TE
,
Li
C
,
Xiong
X
,
Kun
LE
,
Boop
FA
,
Sanford
RA
.
Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study
.
Lancet Oncol
.
2009
Mar
;
10
(
3
):
258
66
.
[PubMed]
1470-2045
23.
Nazar
GB
,
Hoffman
HJ
,
Becker
LE
,
Jenkin
D
,
Humphreys
RP
,
Hendrick
EB
.
Infratentorial ependymomas in childhood: prognostic factors and treatment
.
J Neurosurg
.
1990
Mar
;
72
(
3
):
408
17
.
[PubMed]
0022-3085
24.
Pollack
IF
,
Gerszten
PC
,
Martinez
AJ
,
Lo
KH
,
Shultz
B
,
Albright
AL
, et al.
Intracranial ependymomas of childhood: long-term outcome and prognostic factors
.
Neurosurgery
.
1995
Oct
;
37
(
4
):
655
66
.
[PubMed]
0148-396X
25.
Robertson
PL
,
Zeltzer
PM
,
Boyett
JM
,
Rorke
LB
,
Allen
JC
,
Geyer
JR
, et al.
Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children’s Cancer Group
.
J Neurosurg
.
1998
Apr
;
88
(
4
):
695
703
.
[PubMed]
0022-3085
26.
Sheline
GE
.
Radiation therapy of tumors of the central nervous system in childhood
.
Cancer
.
1975
Mar
;
35
(
3
suppl
):
957
64
.
[PubMed]
0008-543X
27.
Hoppe-Hirsch
E
,
Brunet
L
,
Laroussinie
F
,
Cinalli
G
,
Pierre-Kahn
A
,
Rénier
D
, et al.
Intellectual outcome in children with malignant tumors of the posterior fossa: influence of the field of irradiation and quality of surgery
.
Childs Nerv Syst
.
1995
Jun
;
11
(
6
):
340
5
.
[PubMed]
0256-7040
28.
Vitanza
NA
,
Partap
S
.
Pediatric Ependymoma
.
J Child Neurol
.
2016
Oct
;
31
(
12
):
1354
66
.
[PubMed]
0883-0738
29.
Mohankumar
KM
,
Currle
DS
,
White
E
,
Boulos
N
,
Dapper
J
,
Eden
C
, et al.
An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes
.
Nat Genet
.
2015
Aug
;
47
(
8
):
878
87
.
[PubMed]
1061-4036
30.
Mack
SC
,
Witt
H
,
Piro
RM
,
Gu
L
,
Zuyderduyn
S
,
Stütz
AM
, et al.
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
.
Nature
.
2014
Feb
;
506
(
7489
):
445
50
.
[PubMed]
0028-0836
31.
Vinchon
M
,
Leblond
P
,
Noudel
R
,
Dhellemmes
P
.
Intracranial ependymomas in childhood: recurrence, reoperation, and outcome
.
Childs Nerv Syst
.
2005
Mar
;
21
(
3
):
221
6
.
[PubMed]
0256-7040
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.